ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 315 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is 0.54 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $3,000 | -40.0% | 97 | -17.8% | 0.00% | 0.0% |
| Q1 2022 | $5,000 | -44.4% | 118 | -12.6% | 0.00% | 0.0% |
| Q4 2021 | $9,000 | +12.5% | 135 | +3.8% | 0.00% | 0.0% |
| Q3 2021 | $8,000 | -11.1% | 130 | +16.1% | 0.00% | -50.0% |
| Q2 2021 | $9,000 | +28.6% | 112 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $7,000 | -30.0% | 112 | -9.7% | 0.00% | -33.3% |
| Q4 2020 | $10,000 | +100.0% | 124 | 0.0% | 0.00% | +50.0% |
| Q3 2020 | $5,000 | 0.0% | 124 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $5,000 | +25.0% | 124 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $4,000 | – | 124 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,303 | $54,386,000 | 28.54% |
| JOHNSON & JOHNSON | 3,260,869 | $216,196,000 | 24.61% |
| ACT CAPITAL MANAGEMENT, LLC | 210,500 | $13,956,000 | 10.09% |
| Aquilo Capital Management, LLC | 700,426 | $46,438,000 | 5.27% |
| WEALTH EFFECTS LLC | 145,960 | $9,677,000 | 4.02% |
| Evolutionary Tree Capital Management, LLC | 115,580 | $7,663,000 | 3.68% |
| ACUTA CAPITAL PARTNERS, LLC | 105,500 | $6,995,000 | 2.94% |
| Privium Fund Management B.V. | 204,393 | $13,766,000 | 2.73% |
| L1 Capital Pty Ltd | 292,735 | $19,408,000 | 2.24% |
| Avidity Partners Management LP | 875,000 | $58,013,000 | 1.23% |